Studies have shown that PD-L1 expression in PLEC is elevated compared to the average levels observed in NSCLC, suggesting that immunotherapy may be a promising treatment strategy for PLEC (18, 64). The gene discussed is CD274; the disease is non-small cell lung carcinoma.